DrugEYE™, Data-driven drug discovery
Customer needs and expectations are changing rapidly, and traditional multi-criteria segmentation or clustering methods are no longer sufficient to act on the rapidly changing customer needs. The solutions allows to anticipate on customer needs based on a robust modelling of their behaviour and preferences, giving your company a leap ahead of the competition.
- AI inferred customer segmentation
- Automatic update of the segmentation identifying emerging customer behavioural patterns
- Ongoing recommendation engine for up-selling, cross-selling, Next Best Opportunities, Next Best Actions, best channel
Related news
Did you know that the global construction market will be worth $15 trillion by 2025 at a CAGR of 7%? That is a huge market. And yet it is a…
Digital Transformation is an umbrella term for how businesses adapt their business models to accommodate new technologies like Artificial Intelligence (AI) and big data analytics, enabling them to understand their…
MajestEYE was selected by JICA, the Japanese International Cooperation Agency, among the top 10 most innovative start-ups in Africa for its Artificial Intelligence solution DrugEYE™, which sets to disrupt the…
''Data! Data! Data! I cannot make bricks without clay"-Sherlock Holmes. Everyone knows that data is important to a start-up, but it's more complicated than that. Data is the foundation on…
